|
Size of CEPH relative to its Competitors
(Revenue and Income for the trailing 12 Months ending in , in Millions of $)
|
Select the Relationship:
|
|
Select the Category:
|
|
| COMPANY NAME |
TICKER |
MARKET CAP |
REVENUES
12 Months ending
|
INCOME
12 Months ending
|
ASSETS
AS OF
|
| Cephalon, Inc. |
CEPH |
0 |
0.00 |
0.00 |
- |
| Abbott Laboratories |
ABT |
193,931 |
44,514.00 |
7,725.00 |
74,007.00 |
| Bristol myers Squibb Company |
BMY |
173,223 |
46,960.00 |
6,268.00 |
103,034.00 |
| Eli Lilly And Company |
LLY |
295,541 |
29,322.80 |
6,129.30 |
46,919.30 |
| Johnson and Johnson |
JNJ |
486,823 |
94,880.00 |
19,830.00 |
178,355.00 |
| Merck and Co Inc |
MRK |
239,281 |
52,525.00 |
14,189.00 |
106,668.00 |
| Mylan N v |
MYL |
8,208 |
16,861.30 |
266.40 |
31,243.10 |
| Pfizer Inc |
PFE |
295,944 |
92,367.00 |
25,009.00 |
183,841.00 |
| Enact Holdings Inc |
ACT |
3,473 |
4,921.24 |
1,223.62 |
5,792.41 |
| Amgen Inc |
AMGN |
134,918 |
32,341.00 |
5,723.00 |
59,196.00 |
| Celgene Corp |
CELG |
78,961 |
16,982.00 |
1,834.00 |
41,363.00 |
| Abbvie Inc |
ABBV |
273,506 |
56,725.00 |
12,487.00 |
143,211.00 |
|
SUBTOTAL |
2,183,809.13 |
488,399.34 |
100,684.32 |
973,629.81 |
|
